SEC Comment Letter for Tonix Pharmaceuticals Holding Corp. (TNXP) (CIK 0001430306) (TNXP) — Jan 5, 2011

Tonix Pharmaceuticals Holding Corp. (TNXP) (CIK 0001430306)
Date: Jan. 5, 2011 · CIK: 0001430306 · Accession: 0000000000-11-000627

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-150149

Referenced dates: December 14, 2010

Date

January 5, 2011

Author

Ethan M. Horowitz

Form

UPLOAD

Company

Tonix Pharmaceuticals Holding Corp. (TNXP) (CIK 0001430306)

Letter

January 5, 2011 Mr. David J. Moss President, Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer and Director Tamandare Explorations Inc. 23046 Avenida de la Carlota, Suite 600 Laguna Hills, CA 92653 Re: Tamandare Explorations Inc. Form 10-K for Fiscal Year Ended December 31, 2009 Filed February 16, 2010 Response Letter Dated December 14, 2010 File No. 333-150149

Dear Mr. Moss: We have completed our review of your fili ngs, and do not have any further comments at this time. Sincerely,

Ethan M. Horowitz Branch Chief

Show Raw Text

January 5, 2011
 Mr. David J. Moss President, Chief Executive Officer, Chief Financial Officer,  Secretary, Treasurer and Director Tamandare Explorations Inc.
23046 Avenida de la Carlota, Suite 600
Laguna Hills, CA 92653
Re: Tamandare Explorations Inc.
 Form 10-K for Fiscal Year Ended December 31, 2009
Filed February 16, 2010 Response Letter Dated December 14, 2010 File No. 333-150149

Dear Mr. Moss:
 We have completed our review of your fili ngs, and do not have any further comments at
this time.
Sincerely,

Ethan M. Horowitz Branch Chief

SecProbe.io